Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “Alseres Pharmaceuticals, Inc.”

6 pharma patents match "Alseres Pharmaceuticals, Inc." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 6
Index total 30,257
Page 1 / 1

Quick answer

This filtered view shows 6 pharmaceutical patents matching "Alseres Pharmaceuticals, Inc." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

6 results for “Alseres Pharmaceuticals, Inc.” · 30,257 patents in full index Clear search

  1. US 9757483

    Labeled iodinated tropane formulation

    Alseres Pharmaceuticals, Inc. · Granted Sep 12, 2017 · Expires Sep 7, 2037

    granted

  2. US 8986653

    Labeled iodinated tropane formulation

    Alseres Pharmaceuticals, Inc. · Granted Mar 24, 2015 · Expires Mar 19, 2035

    granted

  3. US 8574545

    Labeled iodinated tropane formulation

    Alseres Pharmaceuticals, Inc. · Granted Nov 5, 2013 · Expires Oct 31, 2033

    granted

  4. US 8133861

    Systemic purine administration: modulating axonal outgrowth of central nervous system neurons

    Alseres Pharmaceuticals, Inc. · Granted Mar 13, 2012 · Expires Mar 8, 2032

    granted

  5. US 8084018

    Methods for imaging dopamine transporter level

    Alseres Pharmaceuticals, Inc. · Granted Dec 27, 2011 · Expires Dec 22, 2031

    granted

  6. US 7452866

    Methods of inhibiting angiogenesis with fragments and homologs of troponin subunit 1

    Alseres Pharmaceuticals, Inc. · Granted Nov 18, 2008 · Expires Nov 13, 2028

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.